Insider Dr. Vuori Buys 15,000 Zero‑Cost Options Amid Turbulent Shares – A Quiet Bet on Inhibrx’s Upside
Insider option buying at Inhibrx signals confidence amid volatility; learn how Dr. Vuori’s 15,000‑share purchase may stabilize shares and boost future growth.
3 minutes to read

